netFormulary NHS
NHS BaNES CCG, NHS Swindon CCG, NHS Wiltshire CCG
Royal United Hospitals Bath NHS Foundation Trust
Great Western Hospitals NHS Foundation Trust
Salisbury NHS Foundation Trust
 Search
News
News Title
news

Covid-19 - AND SEE BOTTOM LEFT OF THIS PAGE
 
- Covid-19: Guidance for the public here.
- Covid-19: Guidance for HCPs here.

During the Covid-19 outbreak, clinicians in England should submit reports of suspected side effects to medicines or medical devices using the Yellow Card Scheme electronically (rather than by paper) via the Yellow Card website or the free Yellow Card app [from the Apple App Store or Google Play Store] to enable early identification of trends.

    
01/04/2020
   
news

25th March 2020 - MHRA statement on cloroquine and hydroxychloroquine for COVID-19 - Until we have clear, definitive evidence that these treatments are safe and effective for the treatment of COVID-19, chloroquine and hydroxychloroquine should only be used for this purpose within a clinical trial

    
01/04/2020
   
news

27 Mar 2020 - Safe switching of warfarin to DOACs for patients with NVAF and VTE (DVT / PE) during the coronavirus pandemic 

    
27/03/2020
   
news

Mar 2020 - Ulipristal (Esmya) removed from formulary: suspension of license due to risk of serious liver injury 

    
20/03/2020
   
news

Mar 2020 - MHRA DSU Tofacitinib (Xeljanz▼): new measures to minimise risk of VTE and of serious and fatal infections

    
20/03/2020
   
news

Mar 2020 - MHRA DSU Baricitinib (Olumiant▼): risk of venous thromboembolism

    
20/03/2020
   
news

Feb 2020 - Diamorphine hydrochloride injection 5mg and 10mg ampoules - Supply Disruption Alert

    
28/02/2020
   
news

Feb 2020 - Epanutin (phenytoin) 30mg/5ml Oral Suspension - Supply Disruption Alert

    
28/02/2020
   
news

Feb 2020 MHRA DSU - Ingenol mebutate gel (Picato▼): suspension of licence due to risk of skin malignancy

    
28/02/2020
   
news

Feb 2020 MHRA DSU - Lemtrada▼ (alemtuzumab): updated restrictions and strengthened monitoring requirements following review of serious cardiovascular and immune-mediated reactions

    
28/02/2020
   
news

Feb 2020 MHRA DSU - Valproate (Epilim▼, Depakote▼) pregnancy prevention programme: updated educational materials 

    
28/02/2020
   
news

Feb 2020 MHRA DSU - Nexplanon (etonogestrel) contraceptive implants: new insertion site to reduce rare risk of neurovascular injury and implant migration

    
28/02/2020
   
news

Jan 2020 -  Note - Discontinuation of 3 Insuman presentations (recombinant human insulin). 

    
05/02/2020
   
news

Jan 2020 - Ingenol mebutate (Picato®) gel has been removed from the formulary and the BSW Actinic keratoses pathway  as a precautionary measure following the MHRA Class 2 recall

    
29/01/2020
   
news

Jan 2020 - MHRA Drug Safety Update Ondansetron - Small increased risk of oral clefts following use in the first 12 weeks of pregnancy

    
29/01/2020
   
news

January 2020 - Phenytoin Sodium NRIM 100mg capsules – Supply Disruption Alert

    
16/01/2020
   
news

January 2020 - Convulex (Valproic acid) 150mg, 300mg and 500mg capsules - Supply Disruption Alert

    
08/01/2020
   
news

Dec 2019 - Ranitidine - Supply Disruption Alert – SECOND UPDATE - all oral formulations (open PDF in link
This additional document produced by SFT may be helpful for paediatric queries PPIs IN PAEDIATRICS

    
20/12/2019
   
news

December 2019 - BSW cannabis-based medicinal products - interim position statement in response to publication of NICE guideline that covers prescribing of cannabis-based medicinal products for people with intractable nausea and vomiting, chronic pain, spasticity and severe treatment-resistant epilepsy.  

    
11/12/2019
   
news

December 2019 - Prescribers may now prescribe and pharmacists may now supply antiviral medicines for the prophylaxis and treatment of influenza at NHS expense. See here

    
03/12/2019
   
news

November 2019: Slo-phyllin (Theophylline) 60mg/125mg/500mg capsules out of stock by end November 2019. See here for MHRA advice on management of patients currently using this medicine.

    
28/11/2019
   
news

November 2019 - Shortage of procyclidine (Kemadrin) 5mg/ml injection

    
06/11/2019
   
news

November 2019 - Discontinuation of glibenclamide 2.5 and 5.0 mg Tablets

    
05/11/2019
   
news

October 2019 - Shortage of salofalk (mesalazine) suppositories (500mg and 1g)

    
25/10/2019
   
news

October 2019 - Drug Safety Update - Prescribing medicines in renal impairment: using the appropriate estimate of renal function to avoid the risk of adverse drug reactions

    
24/10/2019
   
news

October 2019 - Adrenaline auto-injectors: Summary of recent action taken to support safety

    
22/10/2019
   
news

October 2019 - Shortage of phenelzine (Nardil) tablets

    
16/10/2019
   
news

Updated Sep 25th 2019 - Hormone Replacement Therapy (HRT) Supply Issues

    
03/10/2019
   
news

September 2019 - Updated (2019) PHE guidance on use of antiviral agents for the treatment and prophylaxis of seasonal influenza

    
30/09/2019
   
news

September 2019 -  DHSC advice - How healthcare providers can prepare for brexit

    
24/09/2019
   

 

 

 

 


netFormulary